Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.19.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2018
Dec. 31, 2017
Current assets    
Cash $ 8,222,119 $ 1,535,022
Prepaid expenses and other current assets 238,040 88,467
Total current assets 8,460,159 1,623,489
Equipment, net 36,271 16,191
Total assets 8,496,430 1,639,680
Current liabilities    
Accounts payable 1,738,837 863,465
Accrued expenses and other current liabilities 1,330,746 706,964
Senior Secured Convertible Note at fair value, face value principal of $7,750,000 7,903,000
Series A Warrants derivative liability 761,123
Series A Convertible Preferred Stock conversion option derivative liability 212,217
Total current liabilities 10,972,583 2,543,769
Senior Secured Note, net of $3,244,274 unamortized debt discount 1,944,268
Total liabilities 10,972,583 4,488,037
COMMITMENTS AND CONTINGENCIES (NOTE 9)
Stockholders' Equity (Deficit)    
Common stock, par value $0.001; 75,000,000 shares authorized, 27,142,979 shares and 14,551,234 shares issued and outstanding as of December 31, 2018 and December 31, 2017, respectively 27,143 14,551
Additional paid-in capital 32,619,282 14,012,053
Accumulated deficit (36,992,911) (17,907,611)
Total PAVmed Inc. stockholders' deficit (2,314,641) (2,848,357)
Noncontrolling interest in majority-owned subsidiary (161,512)
Total stockholders' deficit (2,476,153) (2,848,357)
Total Liabilities, Series A Convertible Preferred Stock, and Stockholders' Deficit 8,496,430 1,639,680
Series A Convertible Preferred Stock [Member]    
Series A Convertible Preferred Stock    
Temporary equity value
Series B Convertible Preferred Stock [Member]    
Stockholders' Equity (Deficit)    
Convertible Preferred Stock 2,031,845
Series A-1 Convertible Preferred Stock [Member]    
Stockholders' Equity (Deficit)    
Convertible Preferred Stock $ 1,032,650